Journal of Acupuncture Research

  • Volume 41
  • /
  • Pages.228-244
  • /
  • 2024
  • /
  • 2586-288X(pISSN)
  • /
  • 2586-2898(eISSN)
Korean Acupuncture & Moxibustion Medicine Society (대한침구의학회)
권호 표지
DOI QR코드

DOI QR Code

Literature Review of Domestic Randomized Controlled Trials for Hominis Placenta Pharmacopuncture

  • Hea Sun Chun (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University)
  • Received : 2024.08.07
  • Accepted : 2024.10.24
  • Published : 2024.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study was conducted to analyze research trends, quality, and bias of pharmacopuncture studies, etc., on domestic randomized controlled trials (RCTs) using hominis placenta pharmacopuncture (HPP). A total of 13 domestic RCTs were selected by searching two domestic online databases (Research Information Sharing Service and Oriental Medicine Advanced Searching Integrated System). The publication of domestic RCTs using HPP began in 2000, and most studies targeted peripheral facial paralysis and gynecological diseases. Most studies have shown the Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) checklist reporting rate of > 50.0%; however, four subitems, including "depth of insertion," showed a reporting rate < 50.0%. Some studies have shown significant improvement in the HPP group; however, the sample size was diverse, the observation period was short, the effect of stimulation of the same acupoint between the two groups could not be ruled out, and the overall risk of bias was mostly "some concern." In addition, further development of STRICTA that reflects the characteristics of pharmacopuncture therapy is necessary.

Keywords

References

  1. Korean Acupuncture & Moxibustion Medicine Society Textbook Complication Committee. Acupuncture medicine. Rev. ed. Hanmibook. 2021:204-205.
  2. Park SU. The essence of pharmacopuncture - pain. Wooripub. 2020:3, 37.
  3. Korean Pharmacopuncture Institute Textbook Complication Committee. Pharmacopuncturology. Hanmibook. 2019:21.
  4. Lee SK, Lee JD, Koh HK, Park DS, Lee YH, Kang SK. The study on the Hominis Placenta aqua-acupuncture solution. J Korean Acupunct Moxibustion Soc 2000;17:67-74.
  5. Han SS, Koo CM, Hong KE, Park YC, Choi SM. About the problem and improvement plan on acupuncture treatment in clinical trial based on EBM. J Korean Acupunct Moxibustion Soc 2006;23:1-8.
  6. Park BK, Cho JH, Son CG. Randomized clinical controlled trials with herbal acupuncture (pharmacopuncture) in Korea - a systematic review. J Korean Orient Med 2009;30:115-126.
  7. Jang MK, Yoon EH, Jung CY, Kim EJ, Lee SD, Hwang MS, et al. Review of randomized controlled trials on pharmacopuncture treatment for musculoskeletal diseases. J Korean Acupunct Moxibustion Soc 2009;26:149-163.
  8. Sin MS, Park CJ, Choi SW, Yook TH. Clinical studies on herbal acupuncture therapy in peripheral facial palsy. J Pharmacopunct 2001;4:27-33.
  9. Park JH, Jang SH, Lee CH, Ku JY, Jeun DS, Ahn CB, et al. The clinical research of the effectiveness of pharmacopuncture complex therapy on peripheral facial paralysis - Hominis Placenta pharmacopuncture therapy and sweet bee venom therapy. J Korean Acupunct Moxibustion Soc 2010;27:79-87.
  10. Kim TH, Park KY, Park JY. The effect of Hominis Placenta herbal aupuncture therapy on the postpartum women's heat feeling, sweat and thirst. J Orient Obstet Gynecol 2010;23:139-155. doi: 10.15204/jkobgy.2010.23.3.139
  11. Kim SM, Jang SH, Kim CH, Youn HM, Song CH, Ahn CB, et al. Effect of Hominis placenta pharmacopuncture on the dysmenorrhea (a pilot study, single blind, randomized, controlled clinical trial). J Pharmacopunct 2008;11:123-131.
  12. Yoo HS, Kang WC, Cho JH, Lee YW, Son CG, Cho CK. Effects of Hominis Placenta Herbal Acupuncture (HPA) on menstrual cramps. J Pharmacopunct 2005;8:45-49.
  13. Chang SY, Kim HJ, Lee DY, Lee EY. Effect of Hominis Placenta Herbal Acupuncture on dysmenorrhea. J Korean Acupunct Moxibustion Soc 2005;22:85-92.
  14. Yun JH, Yook TH, Song BY. The effect of Hominis placenta herbal acupuncture on Bell's palsy. J Korean Inst Herb Acupunct 2000;3:89-99.
  15. Youn HM, Lee CW, Kim HK. The effects of the Hominis Placenta herbal acupuncture on sleep pattern disturbance. J Pharmacopunct 2005;8:5-12.
  16. Lee CW, Kim HG, Heo SW, Jung KK, Ahn CB, Song CH, et al. The clinical study about Hominis Placenta herbal acupuncture on Bell's palsy. J Pharmacopunct 2005;8:87-97.
  17. Park KB, Song KH, Lee JS, Jo JH. Study on clinical effects of Homnis Placenta Herbal Acupuncture on osteoarthritis of knee joint. J Korean Acupunct Moxibustion Soc 2006;23:163-173. doi: 10.13045/jar.2020.00451
  18. Noh JH, Park JA, Youn HM, Jang KJ, Song CH, Ahn CB, et al. The effect of Hominis Placenta Pharmacopuncture on leg spasticity of stroke patients (a pilot study, double blind, randomized, controlled clinical trial). J Pharmacopunct 2009;12:97-110.
  19. Kim YN, Eom YJ, Kwon DH, Lee JH, Jung IC, Cho E, et al. Effect of Hominis placenta pharmacopuncture for a patient with mild cognitive impairment: a randomized, double-blind, placebo-controlled, multi-center trial. J Orient Neuropsychiatry 2021;32:81-93. doi: 10.7231/jon.2021.32.2.081
  20. Choi SJ, Kim DI, Yoon SH, Choi CM, Yoo JE. Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women. Integr Med Res 2022;11:100891. doi: 10.1016/j.imr.2022.100891
  21. Lee HS, Cha SJ, Park HJ, Seo JC, Park JB, Lee HJ. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT Statement. Korean J Acupunct 2010;27:1-23.
  22. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. John Wiley & Sons. 2019:205-225.
  23. Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. doi: 10.1136/bmj.l4898
  24. Kim SY, Park DA, Seo HJ, Shin SS, Lee SJ, Jang BH, et al. NECA's guidance for assessing tools of risk of bias. National Evidence-based Healthcare Collaborating Agency. 2021:77.
  25. Lee MH, Son IC. Introduction to the aqua-acupuncture therapy and problems. J Korean Acupunct Moxibustion Soc 1998;15:511-518.
  26. Hong KE. Analysis study of survey for safety and efficacy of pharmacopuncture. J Pharmacopunct 2010;13:91-102.
  27. Kang DI, Kwon KR. A report on the manufacturing process of Korean herbal acupuncture prepared with KGMP. J Pharmacopunct 2001;4:87-101.
  28. Lee YJ, Jang BH, Go HY, Hyun MK, Park SY, Lee CH, et al. The assessment of risk of bias on randomised controlled trials of oriental medicine in Korea. J Orient Obstet Gynecol 2011;24:105-113. doi: 10.15204/jkobgy.2011.24.4.105
  29. Korean Association of Herbology Editorial Committee. Herbology. Younglimsa. 2004:619-620.
  30. Kim KY. Sample size estimation using nomogram in dental research. J Korean Dent Assoc 2016;54:630-638. doi: 10.22974/jkda.2016.54.8.004
  31. Jeong MJ, Kwon OG, Woo CH, An HD. Dose dependent effects of Jungsongouhyul pharmacopuncture on Low Back Pain. J Pharmacopunct 2011;14:45-52.
  32. Yang SB, Kim JH. Dose effects of bee venom pharmacopuncture for the acute ankle sprain in rats. Korean J Acupunct 2016;33: 194-203. doi: 10.14406/acu.2016.024
  33. Jun BC. Difference of effectiveness according to pharmacopuncture treatment depth on lumbar spinal herniated intervertebral disc: a randomized controlled trial. J Sports Korean Med 2012;12:73-84.
  34. Eom JH. Constitutional review and legislative tasks to ensure fairness of thesis: focusing on authorship and IRB operation. Sci Technol Law 2019;10:187-215.
  35. Clinical Research Applications to Practice Complication Committee. Clinical research applications to practice. Hyunmoon. 2019:112.
  36. Chung EJ, Baik SJ. A study on policy measures for non-compliance with Institutional Bioethics Committees. Korean J Med Ethics 2020;23:19-37. doi: 10.35301/ksme.2020.23.1.19
  37. Shin HY. Concept and operation of Institutional Review Board and Human Research Protection Program. Bio Ethics Policy 2022;6:53-69. doi: 10.23183/konibp.2022.6.2.003